Literature DB >> 23977541

Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery.

Marjorie G Zauderer1, Lee M Krug.   

Abstract

Entities:  

Year:  2012        PMID： 23977541      PMCID： PMC3741800          DOI： 10.3978/j.issn.2225-319X.2012.10.08

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  24 in total

1.  The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.

Authors:  V W Rusch; S Piantadosi; E C Holmes
Journal:  J Thorac Cardiovasc Surg       Date:  1991-07       Impact factor: 5.209

2.  Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

Authors:  P E Van Schil; P Baas; R Gaafar; A P Maat; M Van de Pol; B Hasan; H M Klomp; A M Abdelrahman; J Welch; J P van Meerbeeck
Journal:  Eur Respir J       Date:  2010-06-04       Impact factor: 16.671

3.  Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.

Authors:  Kenneth E Rosenzweig; Marjorie G Zauderer; Benjamin Laser; Lee M Krug; Ellen Yorke; Camelia S Sima; Andreas Rimner; Raja Flores; Valerie Rusch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-18       Impact factor: 7.038

4.  Trimodality management of malignant pleural mesothelioma.

Authors:  G Maggi; C Casadio; R Cianci; O Rena; E Ruffini
Journal:  Eur J Cardiothorac Surg       Date:  2001-03       Impact factor: 4.191

5.  Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results.

Authors:  Federico Rea; Giuseppe Marulli; Luigi Bortolotti; Cristiano Breda; Adolfo Gino Favaretto; Lucio Loreggian; Francesco Sartori
Journal:  Lung Cancer       Date:  2007-04-02       Impact factor: 5.705

6.  A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors:  V W Rusch; K Rosenzweig; E Venkatraman; L Leon; A Raben; L Harrison; M S Bains; R J Downey; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 5.209

7.  Trimodality therapy for malignant pleural mesothelioma.

Authors:  Gordon Buduhan; Shekhar Menon; Ralph Aye; Brian Louie; Vivek Mehta; Eric Vallières
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

8.  Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Ronald Feld; B C John Cho; Andrea Bezjak; Masaki Anraku; Ronald Burkes; Heidi Roberts; Ming S Tsao; Natasha Leighl; Shaf Keshavjee; Michael R Johnston
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

9.  Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Authors:  Lee M Krug; Harvey I Pass; Valerie W Rusch; Hedy L Kindler; David J Sugarbaker; Kenneth E Rosenzweig; Raja Flores; Joseph S Friedberg; Katherine Pisters; Matthew Monberg; Coleman K Obasaju; Nicholas J Vogelzang
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

10.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209
View more
  4 in total

1.  Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.

Authors:  Marcher R Thompson; Vishruta A Dumane; Stanislav A Lazarev; Yaseen Zia; Kenneth E Rosenzweig
Journal:  Pract Radiat Oncol       Date:  2019-01-15

2.  Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.

Authors:  Andreas Rimner; Daniel E Spratt; Marjorie G Zauderer; Kenneth E Rosenzweig; Abraham J Wu; Amanda Foster; Ellen D Yorke; Prasad Adusumilli; Valerie W Rusch; Lee M Krug
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-26       Impact factor: 7.038

3.  Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models.

Authors:  Barbara Nuvoli; Andrea Sacconi; Giancarlo Cortese; Sabrina Germoni; Bruno Murer; Rossella Galati
Journal:  Oncotarget       Date:  2016-07-26

4.  The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3.

Authors:  Elly Marcq; Jonas R M Van Audenaerde; Jorrit De Waele; Céline Merlin; Patrick Pauwels; Jan P van Meerbeeck; Scott A Fisher; Evelien L J Smits
Journal:  Cancers (Basel)       Date:  2021-01-14       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.